Angelo Vacca mainly investigates Angiogenesis, Pathology, Cancer research, Neovascularization and Bone marrow. His Angiogenesis study is related to the wider topic of Internal medicine. His work carried out in the field of Pathology brings together such families of science as Tumor progression and Metastasis.
He studied Cancer research and Vasculogenesis that intersect with Vasculogenic mimicry. The various areas that Angelo Vacca examines in his Neovascularization study include Mast cell, Tryptase, B cell, Basement membrane and Tumor angiogenesis. His study looks at the intersection of Bone marrow and topics like Multiple myeloma with Immunopathology.
His main research concerns Angiogenesis, Cancer research, Internal medicine, Multiple myeloma and Pathology. His biological study spans a wide range of topics, including Immunology, Bone marrow and Endothelial stem cell. His Bone marrow research includes elements of Monoclonal gammopathy of undetermined significance, Stromal cell and Chronic lymphocytic leukemia.
His research in Cancer research intersects with topics in Tumor progression and Vasculogenesis. Angelo Vacca interconnects Gastroenterology, Endocrinology, Surgery and Oncology in the investigation of issues within Internal medicine. His Pathology research integrates issues from Cancer, Metastasis and B cell.
His scientific interests lie mostly in Cancer research, Multiple myeloma, Angiogenesis, Internal medicine and Bone marrow. His Cancer research study also includes
The Angiogenesis study combines topics in areas such as Endothelial stem cell, Vasculogenesis, Tumor microenvironment, Angiogenic Switch and Chemokine. His Internal medicine study integrates concerns from other disciplines, such as Gastroenterology, Oncology and Cardiology. His work deals with themes such as Cytotoxic T cell, Stromal cell and Matrigel, which intersect with Bone marrow.
His primary areas of investigation include Cancer research, Multiple myeloma, Angiogenesis, Bone marrow and Autophagy. His Cancer research study incorporates themes from Cancer, Tumor progression, Function, microRNA and Programmed cell death. He has included themes like Druggability, Cell, Monoclonal antibody and Drug resistance in his Multiple myeloma study.
His Angiogenesis research is multidisciplinary, relying on both Tumor microenvironment, Metastasis and Tumor growth. His Bone marrow study combines topics from a wide range of disciplines, such as Monoclonal gammopathy of undetermined significance, Cytotoxic T cell and Matrigel. His Autophagy course of study focuses on Cell biology and Proinflammatory cytokine, Chemotaxis and Gene knockdown.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Bone marrow angiogenesis and progression in multiple myeloma.
Angelo Vacca;Domenico Ribatti;Luisa Roncali;Girolamo Ranieri.
British Journal of Haematology (1994)
Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma.
Angelo Vacca;Domenico Ribatti;Marco Presta;Monica Minischetti.
Human Erythropoietin Induces a Pro-Angiogenic Phenotype in Cultured Endothelial Cells and Stimulates Neovascularization In Vivo
Domenico Ribatti;Marco Presta;Marco Presta;Angelo Vacca;Angelo Vacca;Roberto Ria;Roberto Ria.
MHC Class I Antigen Processing and Presenting Machinery: Organization, Function, and Defects in Tumor Cells
Patrizia Leone;Eui-Cheol Shin;Federico Perosa;Angelo Vacca.
Journal of the National Cancer Institute (2013)
TIMP‐2 over‐expression reduces invasion and angiogenesis and protects B16F10 melanoma cells from apoptosis
Piera Valente;Gianfranco Fassina;Antonella Melchiori;Luciana Masiello.
International Journal of Cancer (1998)
Chorioallantoic membrane capillary bed: a useful target for studying angiogenesis and anti-angiogenesis in vivo.
Domenico Ribatti;Beatrice Nico;Angelo Vacca;Luisa Roncali.
Anatomical Record-advances in Integrative Anatomy and Evolutionary Biology (2001)
Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells.
Aldo Maria Roccaro;Teru Hideshima;Noopur Raje;Shaji Kumar.
Cancer Research (2006)
Antiangiogenesis Is Produced by Nontoxic Doses of Vinblastine
Angelo Vacca;Monica Iurlaro;Domenico Ribatti;Monica Minischetti.
Expression of MAGE genes in primary and metastatic cutaneous melanoma.
Francis Brasseur;Donata Rimoldi;Danielle Liénard;Danielle Liénard;Bernard Lethé.
International Journal of Cancer (1995)
Bone marrow angiogenesis and mast cell density increase simultaneously with progression of human multiple myeloma.
D Ribatti;A Vacca;B Nico;F Quondamatteo.
British Journal of Cancer (1999)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: